Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-09

Clinical Trial Update: prTMS as an Intervention for Bradykinesia in Parkinson's Disease [NA]

View source ↗

Summary

This clinical trial update notes that prTMS is being studied as an intervention for bradykinesia in Parkinson disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • prTMS

Snippet

Sponsor: Danish Research Centre for Magnetic Resonance | Conditions: Bradykinesia, Parkinson Disease | NA | Status: RECRUITING